Fig. 2: The distribution of risk drugs prescription in people carrying actionable PGx variants.
From: Clinical impact of pharmacogenetic risk variants in a large chinese cohort
The number of people carrying actionable PGx risk variants or HLA types who took (orange) or did not take (blue) the drug for which they were at risk; number above bar denotes those who took the drug for which they were at risk.
